A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli

por Zhang, Yinci, Liu, Xinkuang, Li, Amin, Tang, Xiaolong
Publicado 2022

Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β...

por Zhang, Yinci, Liang, Jiaojiao, Cao, Niandie, Gao, Jiafeng, Song, Li, Tang, Xiaolong
Publicado 2022

Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells

por Li, Amin, Cao, Weiya, Liu, Xueke, Zhang, Yinci, Ma, Yongfang, Xu, Ruyue, Tang, Xiaolong
Publicado 2020

ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway

por Zhang, Yinci, Liang, Jiaojiao, Cao, Niandie, Gao, Jiafeng, Xie, Yinghai, Zhou, Shuping, Tang, Xiaolong
Publicado 2022

Differences in the characteristics and pulmonary toxicity of nano- and micron-sized respirable coal dust

por Zhang, Yinci, Li, Amin, Gao, Jiafeng, Liang, Jiaojiao, Cao, Niandie, Zhou, Shuping, Tang, Xiaolong
Publicado 2022

ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals

por Zhang, Yinci, Cao, Niandie, Gao, Jiafeng, Liang, Jiaojiao, Liang, Yong, Xie, Yinghai, Zhou, Shuping, Tang, Xiaolong
Publicado 2022

PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair

por Xie, Yinghai, Liu, Changwei, Zhang, Yinci, Li, Amin, Sun, Chong, Li, Rui, Xing, Yingru, Shi, Minghong, Wang, Qi
Publicado 2021

Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma

por Tang, Xiaolong, Chen, Longzhou, Li, Amin, Cai, Shiyu, Zhang, Yinci, Liu, Xueke, Jiang, Zhenyou, Liu, Xinkuang, Liang, Yong, Ma, Dong
Publicado 2018

LY-294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF-1α pathway

por Xu, Ruyue, Zhang, Yinci, Li, Amin, Ma, Yongfang, Cai, Wenpeng, Song, Li, Xie, Yinghai, Zhou, Shuping, Cao, Weiya, Tang, Xiaolong
Publicado 2021

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

por Ma, Yongfang, Xu, Ruyue, Liu, Xueke, Zhang, Yinci, Song, Li, Cai, Shuyu, Zhou, Shuping, Xie, Yinghai, Li, Amin, Cao, Weiya, Tang, Xiaolong
Publicado 2021

BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy

por Cao, Weiya, Liu, Xueke, Zhang, Yinci, Li, Amin, Xie, Yinghai, Zhou, Shuping, Song, Li, Xu, Ruyue, Ma, Yongfang, Cai, Shiyu, Tang, Xiaolong
Publicado 2021

Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells

por Li, Amin, Cao, Weiya, Liu, Xueke, Zhang, Yinci, Ma, Yongfang, Xu, Ruyue, Zhang, Rongbo, Liu, Xinkuang, Zhou, Shuping, Wang, Ruikai, Liu, Jiachang, Tang, Xiaolong
Publicado 2020

hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway

por Shen, Jing, Cai, Wenpeng, Ma, Yongfang, Xu, Ruyue, Huo, Zhen, Song, Li, Qiu, Xinyin, Zhang, Yinci, Li, Amin, Cao, Weiya, Zhou, Shuping, Tang, Xiaolong
Publicado 2020

RETRACTED ARTICLE: The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway

por Tang, Xiaolong, Li, Amin, Xie, Chunmei, Zhang, Yinci, Liu, Xueke, Xie, Yinghai, Wu, Binquan, Zhou, Shuping, Huang, Xudong, Ma, Yongfang, Cao, Weiya, Xu, Ruyue, Shen, Jing, Huo, Zhen, Cai, Shuyu, Liang, Yong, Ma, Dong
Publicado 2020

Retraction Note: The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway

por Tang, Xiaolong, Li, Amin, Xie, Chunmei, Zhang, Yinci, Liu, Xueke, Xie, Yinghai, Wu, Binquan, Zhou, Shuping, Huang, Xudong, Ma, Yongfang, Cao, Weiya, Xu, Ruyue, Shen, Jing, Huo, Zhen, Cai, Shuyu, Liang, Yong, Ma, Dong
Publicado 2021